Erik Rasmussen

The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

Erming Tian, Fenghuang Zhan, Ronald C. Walker et al. · New England Journal of Medicine · 2003 · 1.5K citations · Full text

Medicine, Molecular Biology, Pathology +17

Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

Bart Barlogie, Guido Tricot, Elias Anaissie et al. · New England Journal of Medicine · 2006 · 739 citations

Medicine, Hematology, Oncology +14

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade

David Schaer, Richard P. Beckmann, Jack Dempsey et al. · Cell Reports · 2018 · 460 citations · Full text

Medicine, Immunology, Pharmacology +17

Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma

Max S. Topp, Johannes Duell, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2020 · 299 citations

Medicine, Hematology, Pharmacology +16

Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors

Roy S. Herbst, David S. Hong, Linnea Chap et al. · Journal of Clinical Oncology · 2009 · 242 citations

Medicine, Oncology, Pharmacology +13